PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of brjcancerBJC HomepageBJC Advance online publicationBJC Current IssueSubmitting an article to BJCWeb feeds
 
Br J Cancer. 1990 March; 61(3): 465–468.
PMCID: PMC1971272

Measures of mortality in prostatic cancer.

Abstract

The use of different expressions of mortality in prostate cancer can lead to difficulty in comparing reported data. We have used different measures of mortality in the same group of 438 patients presenting consecutively with histologically proven adenocarcinoma of the prostate, in order to assess the values and deficiencies of each method. The use of expected and relative survival is shown to be valuable in allowing indirect but objective assessment of disease specific mortality in prostatic cancer.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (927K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • George NJ. Natural history of localised prostatic cancer managed by conservative therapy alone. Lancet. 1988 Mar 5;1(8584):494–497. [PubMed]
  • Goodman CM, Busuttil A, Chisholm GD. Age, and size and grade of tumour predict prognosis in incidentally diagnosed carcinoma of the prostate. Br J Urol. 1988 Dec;62(6):576–580. [PubMed]
  • Johansson JE, Adami HO, Andersson SO, Bergström R, Krusemo UB, Kraaz W. Natural history of localised prostatic cancer. A population-based study in 223 untreated patients. Lancet. 1989 Apr 15;1(8642):799–803. [PubMed]
  • Merrick MV, Ding CL, Chisholm GD, Elton RA. Prognostic significance of alkaline and acid phosphatase and skeletal scintigraphy in carcinoma of the prostate. Br J Urol. 1985 Dec;57(6):715–720. [PubMed]
  • Parker MC, Cook A, Riddle PR, Fryatt I, O'Sullivan J, Shearer RJ. Is delayed treatment justified in carcinoma of the prostate? Br J Urol. 1985 Dec;57(6):724–728. [PubMed]
  • Paulson DF, Walther PJ. Is grade or stage of primary importance in determining the outcome after radical prostatectomy for disease clinically confined to the prostate? Br J Urol. 1989 Mar;63(3):301–305. [PubMed]
  • Wilson JM, Kemp IW, Stein GJ. Cancer of the prostate. Do younger men have a poorer survival rate? Br J Urol. 1984 Aug;56(4):391–396. [PubMed]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK